Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA.
Sleep Med Clin. 2022 Dec;17(4):559-567. doi: 10.1016/j.jsmc.2022.07.003. Epub 2022 Oct 9.
Obstructive sleep apnea (OSA) is a common disorder that is increasing in prevalence, both in the United States and worldwide. Continuous positive airway pressure (CPAP), the gold-standard treatment for OSA, is cost-effective from both a payer and societal perspective. Alternative treatments of OSA, including oral appliance therapy, various surgeries, and hypoglossal nerve stimulation have also been evaluated from a cost-effectiveness perspective although results are less consistent. Some studies directly compare these alternative therapies with CPAP. This review will discuss the available literature for cost-effectiveness analysis in the treatment of OSA.
阻塞性睡眠呼吸暂停（OSA）是一种常见疾病，无论是在美国还是在全球，其发病率都在不断上升。持续气道正压通气（CPAP）是 OSA 的金标准治疗方法，从支付者和社会角度来看，具有成本效益。OSA 的替代治疗方法，包括口腔矫治器治疗、各种手术和舌下神经刺激，也从成本效益的角度进行了评估，尽管结果不太一致。一些研究直接比较了这些替代疗法与 CPAP。本综述将讨论治疗 OSA 的成本效益分析的现有文献。
